Legend Biotech Corp
NASDAQ:LEGN
Cash Flow Statement
Cash Flow Statement
Legend Biotech Corp
Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||||||||
Net Income |
(130)
|
(166)
|
(272)
|
(312)
|
(308)
|
(341)
|
(297)
|
(356)
|
(386)
|
(346)
|
(446)
|
(517)
|
(715)
|
(778)
|
(520)
|
|
Depreciation & Amortization |
4
|
7
|
0
|
0
|
10
|
0
|
0
|
0
|
14
|
0
|
18
|
0
|
10
|
15
|
20
|
|
Change in Deffered Taxes |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(1)
|
|
Stock-Based Compensation |
1
|
2
|
2
|
2
|
5
|
7
|
7
|
14
|
20
|
24
|
34
|
0
|
0
|
41
|
48
|
|
Other Non-Cash Items |
(3)
|
(1)
|
0
|
0
|
86
|
0
|
0
|
0
|
32
|
0
|
25
|
0
|
106
|
89
|
132
|
|
Cash Taxes Paid |
15
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
(1)
|
0
|
(4)
|
0
|
0
|
0
|
(0)
|
|
Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
|
Change in Working Capital |
46
|
33
|
128
|
83
|
(11)
|
141
|
93
|
171
|
142
|
96
|
201
|
253
|
240
|
254
|
(25)
|
|
Cash from Operating Activities |
(83)
N/A
|
(125)
-50%
|
(143)
-15%
|
(227)
-59%
|
(223)
+2%
|
(204)
+9%
|
(205)
0%
|
(185)
+10%
|
(199)
-7%
|
(250)
-26%
|
(201)
+20%
|
(264)
-31%
|
(359)
-36%
|
(420)
-17%
|
(393)
+6%
|
|
Investing Cash Flow | ||||||||||||||||
Capital Expenditures |
(39)
|
(55)
|
0
|
0
|
(50)
|
0
|
0
|
0
|
(47)
|
0
|
(22)
|
0
|
(10)
|
(16)
|
(23)
|
|
Other Items |
(20)
|
74
|
105
|
67
|
26
|
(39)
|
(183)
|
(230)
|
(148)
|
(410)
|
(55)
|
173
|
60
|
(143)
|
116
|
|
Cash from Investing Activities |
(59)
N/A
|
39
N/A
|
66
+69%
|
28
-57%
|
(24)
N/A
|
(24)
+2%
|
(183)
-669%
|
(230)
-26%
|
(195)
+15%
|
(410)
-110%
|
(77)
+81%
|
173
N/A
|
50
-71%
|
(159)
N/A
|
93
N/A
|
|
Financing Cash Flow | ||||||||||||||||
Net Issuance of Common Stock |
0
|
150
|
0
|
0
|
624
|
0
|
0
|
0
|
628
|
0
|
381
|
0
|
443
|
795
|
795
|
|
Net Issuance of Debt |
15
|
13
|
0
|
0
|
(3)
|
0
|
0
|
0
|
(1)
|
0
|
(3)
|
0
|
(2)
|
(4)
|
(4)
|
|
Other |
0
|
21
|
608
|
618
|
(3)
|
619
|
312
|
304
|
0
|
626
|
0
|
378
|
727
|
378
|
0
|
|
Cash from Financing Activities |
15
N/A
|
135
+817%
|
602
+347%
|
612
+2%
|
619
+1%
|
470
-24%
|
312
-34%
|
304
-3%
|
627
+106%
|
626
0%
|
378
-40%
|
378
0%
|
1 168
+209%
|
1 169
+0%
|
791
-32%
|
|
Change in Cash | ||||||||||||||||
Effect of Foreign Exchange Rates |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
(0)
|
(3)
|
(5)
|
(3)
|
(3)
|
1
|
|
Net Change in Cash |
(127)
N/A
|
49
N/A
|
525
+969%
|
413
-21%
|
372
-10%
|
244
-35%
|
(74)
N/A
|
(111)
-50%
|
233
N/A
|
(35)
N/A
|
97
N/A
|
282
+191%
|
855
+203%
|
586
-32%
|
492
-16%
|
|
Free Cash Flow | ||||||||||||||||
Free Cash Flow |
(122)
N/A
|
(179)
-46%
|
(143)
+20%
|
(227)
-59%
|
(273)
-20%
|
(204)
+25%
|
(205)
0%
|
(185)
+10%
|
(246)
-33%
|
(250)
-2%
|
(224)
+11%
|
(264)
-18%
|
(370)
-40%
|
(436)
-18%
|
(416)
+5%
|